<DOC>
	<DOCNO>NCT01879735</DOCNO>
	<brief_summary>We wish develop protocol PET/CT examination human use bile acid tracer 11C-cholylsarcosine . This do series PET/CT examination healthy human patient cholestatic disorder .</brief_summary>
	<brief_title>Biliary Excretion Conjugated Bile Acids Humans Measured 11C-cholylsarcosine PET/CT</brief_title>
	<detailed_description>The purpose study development PET/CT protocol use 11C-CSar human use . PET/CT method develop pig study translate study healthy human patient cholestatic disorder . Dynamic PET/CT scan liver biliary system combine measurement tracer concentration radial artery liver vein measurement hepatic blood flow intravenous infusion indocyanine green ( ICG ) /Ficks principle . Kinetic parameter PET/CT measurement invasive measurement compare validation PET estimate parameter refinement PET modeling , require .</detailed_description>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Cholangitis</mesh_term>
	<mesh_term>Cholangitis , Sclerosing</mesh_term>
	<mesh_term>Liver Cirrhosis , Biliary</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Patients cholestatic disorder healthy subject Body weight 110 kg ( catheterization problematic ) . Diabetes Pregnant breast feed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>